×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

India Ophthalmic Viscoelastic Devices Market

ID: MRFR/MED/54236-HCR
200 Pages
Rahul Gotadki
October 2025

India Ophthalmic Viscoelastic Devices Market Research Report: Size, Share, Trend Analysis By Types (Cohesive OVDs, Dispersive OVDs), By Applications (Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery) and By End Users (Ophthalmic Clinics & Phaco Centers, Hospitals, Academic & Research Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

India Ophthalmic Viscoelastic Devices Market Infographic
Purchase Options

India Ophthalmic Viscoelastic Devices Market Summary

As per analysis, the India ophthalmic viscoelastic devices market is projected to grow from USD 117.15 Million in 2024 to USD 200.2 Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.99% during the forecast period (2025 - 2035).

Key Market Trends & Highlights

The India ophthalmic viscoelastic devices market is poised for growth driven by technological advancements and increasing healthcare accessibility.

  • Technological advancements in device design are enhancing the efficacy of ophthalmic procedures.
  • The rising incidence of eye disorders is propelling demand for viscoelastic devices, particularly in cataract surgery.
  • Hospitals remain the largest segment, while ambulatory surgical centers are experiencing the fastest growth in the market.
  • Key market drivers include increasing investment in healthcare infrastructure and growing awareness among patients.

Market Size & Forecast

2024 Market Size 117.15 (USD Million)
2035 Market Size 200.2 (USD Million)
CAGR (2025 - 2035) 4.99%

Major Players

Alcon (CH), Bausch + Lomb (US), Johnson & Johnson (US), Carl Zeiss (DE), Hoya Corporation (JP), Santen Pharmaceutical (JP), Abbott Laboratories (US), Rayner (GB), MediGlobe (DE)

India Ophthalmic Viscoelastic Devices Market Trends

The India ophthalmic viscoelastic devices market is currently experiencing notable growth, driven by advancements in surgical techniques and an increasing prevalence of eye disorders. The rise in cataract surgeries and other ophthalmic procedures has led to a heightened demand for viscoelastic devices, which play a crucial role in maintaining intraocular pressure and protecting ocular tissues during surgery. Furthermore, the Indian government's initiatives to improve healthcare infrastructure and accessibility are likely to enhance the availability of these devices across various regions. As a result, manufacturers are focusing on innovation and product development to meet the evolving needs of healthcare professionals and patients alike. In addition, the market appears to be influenced by the growing awareness of eye health among the Indian population. Educational campaigns and outreach programs are fostering a better understanding of eye conditions, which may lead to increased consultations and subsequent surgical interventions. This trend suggests a potential for sustained growth in the india ophthalmic viscoelastic devices market, as more individuals seek treatment for their eye-related issues. Overall, the combination of technological advancements, government support, and heightened awareness is likely to shape the future landscape of this market in India.

Technological Advancements in Device Design

The india ophthalmic viscoelastic devices market is witnessing a trend towards the development of advanced viscoelastic materials. Innovations in device design are enhancing the performance and safety of these products during surgical procedures. Manufacturers are increasingly focusing on creating viscoelastic devices that offer better stability, lower toxicity, and improved ease of use, which may lead to better surgical outcomes.

Rising Incidence of Eye Disorders

There is a growing prevalence of eye disorders in India, particularly cataracts and glaucoma. This increase is likely to drive demand for ophthalmic surgeries, subsequently boosting the need for viscoelastic devices. As more individuals seek surgical intervention for their eye conditions, the market for these devices is expected to expand, reflecting the urgent need for effective treatment options.

Government Initiatives and Healthcare Accessibility

The Indian government is actively working to enhance healthcare accessibility, particularly in rural areas. Initiatives aimed at improving healthcare infrastructure and providing affordable treatment options are likely to facilitate the distribution of ophthalmic viscoelastic devices. This trend suggests that as healthcare becomes more accessible, the market for these devices may experience significant growth.

India Ophthalmic Viscoelastic Devices Market Drivers

Rising Incidence of Eye Disorders

The increasing prevalence of eye disorders in India is a significant driver for the ophthalmic viscoelastic devices market. With an estimated 62 million people suffering from cataracts and a growing aging population, the demand for surgical interventions is on the rise. This surge in eye-related ailments necessitates the use of viscoelastic devices during surgeries to ensure optimal outcomes. Moreover, the World Health Organization has indicated that uncorrected refractive errors affect a substantial portion of the Indian population, further amplifying the need for effective surgical solutions. Consequently, the rising incidence of eye disorders is likely to propel the growth of the ophthalmic viscoelastic devices market, as healthcare providers seek to adopt advanced technologies to address these challenges.

Growing Awareness and Patient Education

Growing awareness and patient education regarding eye health are emerging as vital drivers for the India ophthalmic viscoelastic devices market. Increased access to information through digital platforms and community outreach programs is empowering patients to seek timely medical intervention for eye disorders. As individuals become more informed about the benefits of surgical treatments, the demand for procedures utilizing viscoelastic devices is expected to rise. Moreover, healthcare providers are increasingly focusing on educating patients about the importance of regular eye check-ups and the role of advanced surgical techniques in preserving vision. This heightened awareness is likely to contribute to the growth of the ophthalmic viscoelastic devices market, as more patients opt for surgical solutions to address their eye health concerns.

Technological Advancements in Device Design

The India ophthalmic viscoelastic devices market is experiencing a notable transformation due to rapid technological advancements in device design. Innovations such as the development of cohesive and dispersive viscoelastics are enhancing surgical outcomes in cataract and glaucoma procedures. These advancements not only improve the safety and efficacy of surgeries but also reduce the risk of complications. For instance, the introduction of new formulations that provide better stability and clarity is likely to drive market growth. Furthermore, the integration of smart technologies in surgical devices is anticipated to enhance precision during operations. As a result, the demand for advanced viscoelastic devices is expected to rise, reflecting a shift towards more sophisticated surgical techniques in India.

Increasing Investment in Healthcare Infrastructure

The India ophthalmic viscoelastic devices market is benefiting from increasing investments in healthcare infrastructure. The government and private sector are channeling resources into upgrading hospitals and clinics, particularly in tier-2 and tier-3 cities. This investment is aimed at enhancing the quality of eye care services and expanding the reach of advanced surgical procedures. As more healthcare facilities adopt state-of-the-art technologies, the demand for ophthalmic viscoelastic devices is likely to rise. Furthermore, the establishment of specialized eye hospitals is expected to create a conducive environment for the growth of the market, as these institutions often prioritize the use of advanced surgical materials to ensure better patient outcomes.

Government Initiatives and Healthcare Accessibility

Government initiatives aimed at improving healthcare accessibility are playing a crucial role in the growth of the India ophthalmic viscoelastic devices market. The Indian government has launched various programs to enhance eye care services, particularly in rural areas, where access to quality healthcare remains limited. Initiatives such as the National Programme for Control of Blindness and Visual Impairment are designed to increase awareness and provide affordable treatment options. These efforts are likely to boost the demand for ophthalmic surgeries, consequently driving the need for viscoelastic devices. Additionally, the implementation of policies that promote public-private partnerships in healthcare is expected to facilitate the availability of advanced surgical technologies, further supporting market expansion.

Market Segment Insights

By Application: Cataract Surgery (Largest) vs. Glaucoma Surgery (Fastest-Growing)

The India ophthalmic viscoelastic devices market is predominantly shaped by the application in cataract surgery, which accounts for a significant portion of the total market share. Other applications including glaucoma surgery, corneal surgery, and retinal surgery, while important, hold smaller shares in comparison. Glaucoma surgery is increasingly gaining attention as a notable segment, as advancements and patient awareness grow. Overall, the application segmentation reflects a diverse landscape with cataract procedures leading the way.

Cataract Surgery (Dominant) vs. Glaucoma Surgery (Emerging)

Cataract surgery remains the dominant application in the India ophthalmic viscoelastic devices market, characterized by well-established procedural norms and widespread physician acceptance. This segment benefits from a high volume of surgeries annually, driven by the aging population and the increasing incidence of cataracts. On the other hand, glaucoma surgery is emerging swiftly owing to rising awareness regarding the disease and its prevalence. New technologies and innovations in surgical techniques are propelling its growth. Additionally, the understanding of the need for early intervention in glaucoma patients is fostering a shift towards more frequent surgical operations. As a result, both segments present substantial opportunities for players in the market.

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the India ophthalmic viscoelastic devices market, hospitals hold the largest share among end-use segments. This dominance is attributed to their established infrastructure, advanced surgical capabilities, and the high volume of surgeries performed. Ambulatory surgical centers, while smaller in share, are rapidly gaining traction due to their growing preference for outpatient procedures, driving an increase in the adoption of ophthalmic viscoelastic devices. The growth trends for this segment indicate a shift towards minimally invasive surgical techniques, further bolstered by technological advancements in ophthalmic procedures. Hospitals focus on optimizing patient outcomes and reducing surgery times, while ambulatory surgical centers are capitalizing on the demand for cost-effective and convenient surgical options, leading to a significant expansion of their market presence.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals serve as the cornerstone of the India ophthalmic viscoelastic devices market due to their comprehensive services, experienced staff, and advanced technologies in eye surgeries. They offer a wide array of surgical treatments, integrating viscoelastic devices into various procedures, ensuring enhanced patient safety and surgical outcomes. Conversely, ambulatory surgical centers are emerging as key players, focusing on efficiency and patient-centered care. With shorter recovery times, these centers provide an attractive alternative for patients requiring eye surgeries, particularly amid rising healthcare costs. As such, the preference for outpatient care is fostering rapid growth in the ambulatory surgical center segment, positioning it as a significant competitor to hospitals in the evolving ophthalmic market.

By Product Type: Sodium Hyaluronate (Largest) vs. Chondroitin Sulfate (Fastest-Growing)

In the India ophthalmic viscoelastic devices market, Sodium Hyaluronate holds the largest share due to its widespread use and effectiveness in surgical interventions. This product type is favored for its ability to maintain intraocular pressure and protect corneal endothelial cells, making it a staple in cataract surgeries. Meanwhile, Chondroitin Sulfate is gaining momentum and is recognized as the fastest-growing segment, primarily due to rising research efforts and increasing awareness about its benefits in ocular surgeries and therapeutic applications.

Sodium Hyaluronate (Dominant) vs. Chondroitin Sulfate (Emerging)

Sodium Hyaluronate is the dominant product in the India ophthalmic viscoelastic devices market, characterized by its excellent viscoelastic properties, which facilitate smooth surgical maneuvers. It is highly regarded for its biocompatibility and ability to retain water, making it essential in maintaining the anterior chamber during eye procedures. Conversely, Chondroitin Sulfate is an emerging product, noted for its potential to enhance tissue healing and reduce inflammation. With increasing clinical trials and studies supporting its efficacy, Chondroitin Sulfate is poised for rapid growth as surgeons seek innovative solutions to improve surgical outcomes.

By Formulation Type: Pre-filled Syringes (Largest) vs. Vials (Fastest-Growing)

In the Indian ophthalmic viscoelastic devices market, the formulation type segment is primarily dominated by pre-filled syringes, accounting for a substantial share. This segment's ability to provide convenience and accuracy in dosage administration contributes significantly to its market leadership. On the other hand, vials hold a smaller yet notable share, but their usage is rapidly increasing as they become more appealing due to cost-effectiveness and flexibility in various clinical settings. The growth trends within this segment are heavily driven by the rising prevalence of eye-related disorders, emphasizing the need for advanced surgical procedures that leverage these formulations. Furthermore, technological advancements enhancing product safety and efficacy are propelling the adoption of vials. As healthcare infrastructure improves, the emphasis on innovative delivery mechanisms is expected to further bolster the segment's growth trajectory, particularly for vials, which cater to emerging market needs in ophthalmic procedures.

Formulation Type: Pre-filled Syringes (Dominant) vs. Vials (Emerging)

Pre-filled syringes serve as the dominant formulation type in the Indian ophthalmic viscoelastic devices market, favored for their sterility and user-friendly characteristics that reduce the risk of contamination. Their design improves ease of use during surgical interventions, making them highly sought after in clinical settings. Vials, however, represent the emerging formulation group, gaining traction due to their lower cost and multi-dose capabilities, appealing particularly to hospitals and clinics looking for cost-effective solutions. While they lag behind pre-filled syringes in market share, the increasing focus on flexible and scalable treatment options positions vials to capture a significant segment of the market in the near future.

By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the India ophthalmic viscoelastic devices market, the distribution channel is increasingly pivotal. Currently, direct sales account for the largest share due to established relationships between manufacturers and healthcare providers. Distributors also play a significant role, facilitating access to a wider network, though their share is gradually declining compared to more agile channels. Online sales are witnessing rapid growth as healthcare professionals adapt to the convenience of purchasing through digital platforms. This shift is driven by the increasingly digital nature of the healthcare environment and heightened demand for accessibility. The pandemic has further accelerated this trend, establishing a new norm where online channels are expected to see continued expansion and dominance in the coming years.

Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct sales in the Indian ophthalmic viscoelastic devices market maintain a dominant position, characterized by personal interactions and tailored services provided to ophthalmic surgeons and hospitals. This method helps build trust and ensures a thorough understanding of the products, enabling better professional recommendations. Conversely, online sales are emerging rapidly, catering to a tech-savvy demographic that values convenience. This channel appeals particularly to smaller clinics and newer practitioners who prefer the ease of browsing and ordering products from any location. With an increasing number of suppliers investing in e-commerce platforms, online sales are set to capture a larger share of the market, bridging the gap between traditional practices and modern purchasing behaviors.

Get more detailed insights about India Ophthalmic Viscoelastic Devices Market

Key Players and Competitive Insights

The competitive dynamics within the ophthalmic viscoelastic devices market in India are characterized by a blend of innovation, strategic partnerships, and regional expansion. Key players such as Alcon (CH), Bausch + Lomb (US), and Johnson & Johnson (US) are actively shaping the landscape through their operational focuses. Alcon (CH) emphasizes innovation in product development, particularly in enhancing the performance of viscoelastic devices, which appears to be a critical driver of their market presence. Meanwhile, Bausch + Lomb (US) is pursuing strategic partnerships to bolster its distribution channels, thereby enhancing its reach within the Indian market. Johnson & Johnson (US) is also focusing on regional expansion, aiming to tap into the growing demand for advanced ophthalmic solutions in India, which collectively influences the competitive environment by fostering a culture of continuous improvement and responsiveness to market needs.

The market structure is moderately fragmented, with several players vying for market share. Key business tactics such as localizing manufacturing and optimizing supply chains are becoming increasingly prevalent. For instance, companies are investing in local production facilities to reduce costs and improve supply chain efficiency, which is essential in a market where timely delivery and product availability are paramount. This collective influence of key players not only enhances competition but also drives innovation as companies strive to differentiate themselves in a crowded marketplace.

In December 2025, Alcon (CH) announced the launch of a new line of advanced viscoelastic devices designed specifically for cataract surgery, which is expected to enhance surgical outcomes. This strategic move underscores Alcon's commitment to innovation and positions the company to capture a larger share of the growing cataract surgery market in India. The introduction of these devices may significantly improve the efficiency of surgical procedures, thereby attracting more ophthalmic surgeons to adopt Alcon's products.

In November 2025, Bausch + Lomb (US) entered into a strategic partnership with a leading Indian healthcare provider to expand its distribution network for viscoelastic devices. This collaboration is likely to enhance Bausch + Lomb's market penetration and improve accessibility for healthcare professionals across India. By leveraging the established network of the healthcare provider, Bausch + Lomb can ensure that its products reach a wider audience, thereby increasing its competitive edge in the market.

In October 2025, Johnson & Johnson (US) announced an investment in a new manufacturing facility in India dedicated to the production of ophthalmic viscoelastic devices. This investment is indicative of the company's long-term commitment to the Indian market and its strategy to localize production. By establishing a manufacturing base in India, Johnson & Johnson can reduce lead times and costs, which may enhance its competitive positioning in a market that is increasingly focused on efficiency and reliability.

As of January 2026, current trends in the ophthalmic viscoelastic devices market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Companies are increasingly forming strategic alliances to leverage these trends, which are reshaping the competitive landscape. The shift from price-based competition to a focus on innovation and technology is evident, as firms seek to differentiate themselves through advanced product offerings and reliable supply chains. This evolution suggests that future competitive differentiation will hinge on the ability to innovate and adapt to changing market dynamics.

Key Companies in the India Ophthalmic Viscoelastic Devices Market include

Industry Developments

The India Ophthalmic Viscoelastic Devices Market has witnessed significant activity recently. In October 2023, Eagle Vision launched a new line of viscoelastic devices aimed at enhancing surgical outcomes in cataract procedures. MediVision also unveiled advanced formulations for its viscoelastic products to cater to the increasing demand from ophthalmic surgeons across the country.

Furthermore, in September 2023, Abbott Laboratories announced an expansion of its distribution network in India to enhance its market presence. In a notable merger, Bausch Health completed the acquisition of Santen Pharmaceutical’s ophthalmic business in August 2023, a move aimed at consolidating their product offerings in India. The growth of the market is also driven by a rising aging population and an increase in eye-related procedures.

In terms of market valuation, the Indian market for ophthalmic viscoelastic devices is expected to reach USD 300 million by 2025, reflecting a robust growth trajectory. Recent developments, coupled with increasing healthcare investments and technological advancements, are shaping a promising future for key players like Alcon and Johnson and Johnson, who are actively involved in Research and Development for advanced surgical solutions.

Future Outlook

India Ophthalmic Viscoelastic Devices Market Future Outlook

The India ophthalmic viscoelastic devices market is projected to grow at a 4.99% CAGR from 2025 to 2035, driven by increasing surgical procedures and technological advancements.

New opportunities lie in:

  • Expansion of product lines to include biodegradable viscoelastic devices.
  • Development of customized viscoelastic solutions for specific surgical needs.
  • Strategic partnerships with hospitals for exclusive supply agreements.

By 2035, the market is expected to be robust, reflecting sustained growth and innovation.

Market Segmentation

India Ophthalmic Viscoelastic Devices Market End Use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmic Clinics

India Ophthalmic Viscoelastic Devices Market Application Outlook

  • Cataract Surgery
  • Glaucoma Surgery
  • Corneal Surgery
  • Retinal Surgery

India Ophthalmic Viscoelastic Devices Market Product Type Outlook

  • Sodium Hyaluronate
  • Chondroitin Sulfate
  • Hyaluronic Acid
  • Viscoelastic Solutions

India Ophthalmic Viscoelastic Devices Market Formulation Type Outlook

  • Pre-filled Syringes
  • Vials
  • Bulk Solutions

India Ophthalmic Viscoelastic Devices Market Distribution Channel Outlook

  • Direct Sales
  • Distributors
  • Online Sales

Report Scope

MARKET SIZE 2024117.15(USD Million)
MARKET SIZE 2025178.2(USD Million)
MARKET SIZE 2035200.2(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)4.99% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledAlcon (CH), Bausch + Lomb (US), Johnson & Johnson (US), Carl Zeiss (DE), Hoya Corporation (JP), Santen Pharmaceutical (JP), Abbott Laboratories (US), Rayner (GB), MediGlobe (DE)
Segments CoveredApplication, End Use, Product Type, Formulation Type, Distribution Channel
Key Market OpportunitiesGrowing demand for advanced surgical techniques drives innovation in the india ophthalmic viscoelastic devices market.
Key Market DynamicsRising demand for advanced ophthalmic procedures drives growth in India's ophthalmic viscoelastic devices market.
Countries CoveredIndia
Leave a Comment

FAQs

What is the current valuation of the India ophthalmic viscoelastic devices market?

<p>As of 2024, the market valuation was 117.15 USD Million.</p>

What is the projected market size for the India ophthalmic viscoelastic devices market by 2035?

<p>The market is projected to reach 200.2 USD Million by 2035.</p>

What is the expected CAGR for the India ophthalmic viscoelastic devices market during the forecast period?

<p>The expected CAGR for the market from 2025 to 2035 is 4.99%.</p>

Which application segment holds the largest market share in the India ophthalmic viscoelastic devices market?

<p>Cataract surgery appears to hold the largest market share, with valuations ranging from 50.0 to 90.0 USD Million.</p>

What are the key product types in the India ophthalmic viscoelastic devices market?

<p>Key product types include Sodium Hyaluronate, Chondroitin Sulfate, Hyaluronic Acid, and Viscoelastic Solutions.</p>

Which distribution channel is expected to generate the highest revenue in the India ophthalmic viscoelastic devices market?

<p>The distributor channel is likely to generate the highest revenue, with a range of 50.0 to 90.0 USD Million.</p>

What is the market performance of the glaucoma surgery segment in the India ophthalmic viscoelastic devices market?

<p>The glaucoma surgery segment had a market performance ranging from 30.0 to 50.0 USD Million.</p>

Who are the leading players in the India ophthalmic viscoelastic devices market?

<p>Key players include Alcon, Bausch + Lomb, Johnson & Johnson, and Carl Zeiss, among others.</p>

What is the expected market size for ambulatory surgical centers in the India ophthalmic viscoelastic devices market?

<p>The market size for ambulatory surgical centers is projected to range from 30.0 to 50.0 USD Million.</p>

How does the market for pre-filled syringes compare to other formulation types in the India ophthalmic viscoelastic devices market?

<p>The market for pre-filled syringes is expected to range from 35.0 to 60.0 USD Million, indicating a competitive position among formulation types.</p>

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions